Decoding signaling and function of the orphan G protein-coupled receptor GPR17 with a small-molecule agonist
Stephanie Hennen,Haibo Wang,Lucas Peters,Nicole Merten,Katharina Simon,Andreas Spinrath,Stefanie Blättermann,Rhalid Akkari,Ramona Schrage,Ralf Schröder,Daniel Schulz,Celine Vermeiren,Katrin Zimmermann,Stefan Kehraus,Christel Drewke,Alexander Pfeifer,Gabriele M König,Klaus Mohr,Michel Gillard,Christa E Müller,Q Richard Lu,Jesus Gomeza,Evi Kostenis
DOI: https://doi.org/10.1126/scisignal.2004350
2013-10-22
Abstract:Replacement of the lost myelin sheath is a therapeutic goal for treating demyelinating diseases of the central nervous system (CNS), such as multiple sclerosis (MS). The G protein (heterotrimeric guanine nucleotide-binding protein)-coupled receptor (GPCR) GPR17, which is phylogenetically closely related to receptors of the "purinergic cluster," has emerged as a modulator of CNS myelination. However, whether GPR17-mediated signaling positively or negatively regulates this critical process is unresolved. We identified a small-molecule agonist, MDL29,951, that selectively activated GPR17 even in a complex environment of endogenous purinergic receptors in primary oligodendrocytes. MDL29,951-stimulated GPR17 engaged the entire set of intracellular adaptor proteins for GPCRs: G proteins of the Gα(i), Gα(s), and Gα(q) subfamily, as well as β-arrestins. This was visualized as alterations in the concentrations of cyclic adenosine monophosphate and inositol phosphate, increased Ca²⁺ flux, phosphorylation of extracellular signal-regulated kinases 1 and 2 (ERK1/2), as well as multifeatured cell activation recorded with label-free dynamic mass redistribution and impedance biosensors. MDL29,951 inhibited the maturation of primary oligodendrocytes from heterozygous but not GPR17 knockout mice in culture, as well as in cerebellar slices from 4-day-old wild-type mice. Because GPCRs are attractive targets for therapeutic intervention, inhibiting GPR17 emerges as therapeutic strategy to relieve the oligodendrocyte maturation block and promote myelin repair in MS.